3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀå - ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ ¹× ¿¹Ãø(2017-2027³â) : ±¸¼º¿ä¼Òº°, ±â¼úº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±â¾÷º°, Áö¿ªº° ºÐ¼®
3D Protein Structure Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Component, By Technique, By End User, By company and By Region
»óǰÄÚµå : 1289639
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2023³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 116 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,957,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,575,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ¼¼°è ½ÃÀåÀº 2023-2027³âÀÇ ¿¹Ãø ±â°£ µ¿¾È °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÁÖ¿ä ¿äÀÎÀ¸·Î´Â X¼± °áÁ¤±¸Á¶ ºÐ¼® ¿öÅ©Ç÷οìÀÇ ÀÚµ¿È­ ¹× ¼ÒÇüÈ­¿¡ ´ëÇÑ °ü½É Áõ°¡, ÷´Ü ±â¼ú äÅÃ, ¿¬±¸°³¹ß Ȱµ¿ÀÇ È°¼ºÈ­ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ´Ü¹éÁú ±¸Á¶´Â ±âº»ÀûÀ¸·Î ¾Æ¹Ì³ë»ê ¿øÀÚÀÇ 3Â÷¿ø ¹è¿­À» ÀǹÌÇÕ´Ï´Ù. ¿øÀÚ ÇØ»óµµÀÇ ´Ü¹éÁú 3Â÷¿ø ±¸Á¶´Â Å« ´Ü¹éÁúÀ» °áÁ¤È­ÇÏ¿© X¼± ȸÀý·Î ¿¬±¸ÇÔÀ¸·Î½á °áÁ¤µÉ ¼ö ÀÖ½À´Ï´Ù. ´Ü¹éÁúÀÇ ±â´ÉÀº ´Ü¹éÁúÀÇ ±¸Á¶¿Í Á÷Á¢ÀûÀ¸·Î °ü·ÃÀÌ ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÏ´Â ´Ù¸¥ ¿äÀÎÀ¸·Î´Â ´Ü¹éÁú Ä¡·áÁ¦ ¼ö¿ä Áõ°¡, ¸¸¼º Áúȯ, °¨¿° ¹× ´Ü¹éÁú °áÇÌ ÁúȯÀÇ À¯º´·ü Áõ°¡, ¿¬±¸¼Ò ¼ö Áõ°¡, ¸ÂÃãÇü ÀǾàǰ¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä, Á¤ºÎ º¸Á¶±Ý Áõ°¡ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Å¾à °³¹ßÀ» À§ÇÑ R&D ºñ¿ë Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

X¼± °áÁ¤±¸Á¶ ºÐ¼® ¿öÅ©Ç÷οìÀÇ ÀÚµ¿È­¿Í ¼ÒÇüÈ­¿¡ ´ëÇÑ °ü½É Áõ°¡

X¼± °áÁ¤ ±¸Á¶ ºÐ¼®Àº X¼± ȸÀýÀ» ÅëÇØ ´Ü¹éÁúÀÇ ÀÔü ±¸Á¶¸¦ ¾ò´Â ±â¼ú·Î, ´Ü¹éÁúÀÇ ±â´É¼ºÀ» ÆÄ¾ÇÇÏ´Â µ¥ µµ¿òÀÌ µÇ¸ç, X¼± °áÁ¤ ±¸Á¶ ºÐ¼®ÀÇ ÀÚµ¿È­ ¹× ¼ÒÇüÈ­°¡ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. È¿À²ÀûÀ̱⠶§¹®¿¡ ¿öÅ©Ç÷ο쿡 ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, LBNLÀÇ ¹ÙÀÌ¿À ±â±â ÆÀÀº ALS, GNF, Syrx¿Í °øµ¿À¸·Î ½ÌÅ©·ÎÆ®·Ð ºö¶óÀο¡¼­ »ç¿ëÇÒ ¼ö ÀÖ´Â 1¼¼´ë ÀÚµ¿ °áÁ¤ ÀÎ½Ä ¹× Á¤·Ä ½Ã½ºÅÛÀ» °³¹ßÇß½À´Ï´Ù.

½Å¾à ¿¬±¸°³¹ß Áõ°¡

ÃÖ±Ù ¸î ³âµ¿¾È ½Å¾à ¹× ÀǾàǰ °³¹ßÀÇ ¿¬±¸°³¹ß Ȱµ¿ÀÌ È°¹ßÇØÁö¸é¼­ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ±× ¹è°æ¿¡´Â ¸¸¼º ´Ü¹éÁú °áÇÌ Áúȯ°ú °¨¿°¼º Áúȯ Áõ°¡°¡ ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ½ÄǰÀǾ౹(FDA)Àº 2010³âºÎÅÍ 2019³â±îÁö Æò±Õ 38°³ÀÇ ½Å¾àÀ» ½ÂÀÎÇߴµ¥, ÀÌ´Â 10³â Àü Æò±Õº¸´Ù 60% ´õ ¸¹Àº ¼öÄ¡ÀÔ´Ï´Ù. ´Ü¹éÁú ºÐ¼®Àº ÀáÀçÀû È常¦ ½Äº°ÇÏ´Â µ¥ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ´Ü°èÀÔ´Ï´Ù. ¶ÇÇÑ, Æò°¡Á¦¾à(Evaluate Pharma)ÀÇ º¸°í¼­¿¡ µû¸£¸é, 2012³â ¼¼°è ÀǾàǰ ¿¬±¸°³¹ßºñ´Â 1,360¾ï ´Þ·¯·Î Æò°¡µÇ¸ç, 2019³â¿¡´Â 1,860¾ï ´Þ·¯·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù.

±â¼úÀû Áøº¸

´Ü¹éÁú ±¸Á¶ ºÐ¼® Àåºñ¿¡ ´ëÇÑ ±â¼ú °³¹ßÀÌ Áõ°¡Çϸ鼭 ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ´Ü¹éÁú ±¸Á¶¿¡ ´ëÇÑ °íÇØ»óµµ Á¤º¸¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϸ鼭 ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖÀ¸¸ç, X¼± ÇÁ¸® ÀüÀÚ ·¹ÀÌÀú, D8 DISCOVER Plus X¼± ȸÀý(XRD)°ú °°Àº ÷´Ü ±â¼úÀÇ µîÀåÀº ´Ü¹éÁú 3D ±¸Á¶ ºÐ¼®ÀÇ Á¤È®¼º°ú ¼Óµµ Çâ»ó¿¡ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2019³â ¹Ì±¹ ¾ÏÁ¨(Amgen)°ú ¿ö½ÌÅÏ ´ëÇб³ÀÇ ´Ü¹éÁú ¼³°è ¿¬±¸¼Ò(IPD)´Â °øµ¿À¸·Î »õ·Î¿î ±â¼úÀ» Å×½ºÆ®ÇÏ¿© ½Å¾à Ž»ö¿¡ Àû¿ëÇÒ ¼ö ÀÖ´Â ´Ü¹éÁú ±¸Ãà Àü¼úÀ» °³¹ßÇß½À´Ï´Ù.

»ç¿ë °¡´ÉÇÑ Ä¿½ºÅ͸¶ÀÌ¡

±â¼ú°úÇבּ¸´Â Á¤ÇØÁø ½ÃÀå µ¥ÀÌÅ͸¦ ÀÌ¿ëÇÏ¿© ±â¾÷ÀÇ Æ¯Á¤ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇüÀ¸·Î Á¦°øÇÕ´Ï´Ù. º¸°í¼­¿¡¼­ ´ÙÀ½°ú °°Àº Ä¿½ºÅ͸¶ÀÌ¡ÀÌ °¡´ÉÇÕ´Ï´Ù.

±â¾÷ Á¤º¸

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼¼°è 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

Á¦5Àå VOC(°í°´ÀÇ ¼Ò¸®)

Á¦6Àå ¼¼°èÀÇ 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀå Àü¸Á

Á¦7Àå ºÏ¹ÌÀÇ 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀå Àü¸Á

Á¦8Àå À¯·´ÀÇ 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀå Àü¸Á

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀå Àü¸Á

Á¦10Àå ³²¹ÌÀÇ 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀå Àü¸Á

Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀå Àü¸Á

Á¦12Àå ½ÃÀå ¿ªÇÐ

Á¦13Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦14Àå °æÀï ±¸µµ(Á¾ÇÕÀû SWOT ºÐ¼®)

Á¦15Àå Àü·«Àû Ãßõ »çÇ×

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global 3D protein structure analysis market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include a growing focus on automation and miniaturization in X-ray crystallography workflow, adoption of advanced technology, and rise in R&D activities that are augmenting the growth of the market. Protein structure is basically the three-dimensional arrangement of atoms in an amino acid. The three-dimensional structure of a protein at atomic resolution can be determined by crystallizing large proteins and then studying them by x-ray diffraction. Protein function is directly associated with the structure of that protein. The other factors supporting the market's growth are the rising demand for protein therapeutics, the rising prevalence of chronic, infectious, and protein-deficient diseases, the increase in the number of research laboratories, the high demand for personalized medicines, and increasing government grants. Also, the rising research and development (R&D) expenditure for drug discovery and development is facilitating the growth of the market.

Rising Focus on Automation and Miniaturization in X-Ray Crystallography Workflow

X-Ray crystallography is a technique by which the 3D structure of a protein can be obtained by X-ray diffraction, which helps to know the functionality of the protein. Growing emphasis on automation and miniaturization of existing crystallography is augmenting the growth of the market. This automation and miniaturization of x-ray crystallography are positively influencing the workflow by being more effective and efficient in 3D protein structure analysis. For instance, the bio instrumentation team at LBNL collaborated with ALS, GNF's researcher, and Syrrx to develop a first-generation automated crystal recognition and alignment system intended to work at synchrotron beamlines.

Increase in R&D in Drug Discovery and Development

Over the past few years, rising R&D activities in drug discovery and development is bolstering the growth of the market. This is attributed to the rising incidences of chronic, protein-deficient diseases and infectious diseases. For instance, the Food and Drug Administration (FDA) approved an average of 38 new drugs from 2010 to 2019, which is 60% more than the prior decade's average. Protein analysis is a crucial phase in identifying potential candidates. Also, the subsequent rise in R&D expenditure is propelling the growth of the market globally. As per the Evaluate Pharma report, pharmaceutical R&D expenditure globally was valued at USD 136 billion in 2012, which raised to USD 186 billion in 2019.

Technological Advancements

The rise in technological developments in equipment for protein structure analysis is fueling the growth of the market. The growing need for high-resolution information on protein structures is driving the growth of the market. The advent of advanced technologies like X-ray-free electron lasers, D8 DISCOVER Plus X-ray Diffraction (XRD), and others are helpful due to the enhanced accuracy and speed in analyzing the 3D structure of the protein. For instance, in 2019, Amgen (US) and the University of Washington's Institute for Protein Design (IPD) collaborated to test new technologies and generate protein-building tactics that can be applied to seek new drugs.

Market Segmentation

The global 3D protein structure analysis market is segmented into components, techniques, end users, and company. Based on components, the market is divided into instruments, consumables, and software. Based on technique, the market is divided into x-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, cryo-electron microscopy (Cryo-EM), and small angle x-ray scattering (SAXS). Based on end-user, the market is divided into biotechnology & pharmaceutical companies, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising prevalence of chronic and infectious diseases in the country.

Market Players

Bruker Corporation, JEOL Ltd., Spectris plc, Thermo Fisher Scientific Inc., Merck KGaA, Schrodinger, Inc., Cambridge Isotope Laboratories, Inc., Rigaku Corporation, Jena Bioscience GmbH, and Dassault Systemes SE are some of the leading companies operating in the market.

Report Scope

In this report, global 3D protein structure analysis market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

3D Protein Structure Analysis Market, By Component:

3D Protein Structure Analysis Market, By Component:

3D Protein Structure Analysis Market, By End User:

3D Protein Structure Analysis Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global 3D Protein Structure Analysis Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global 3D Protein Structure Analysis Market

5. Voice of Customer

6. Global 3D Protein Structure Analysis Market Outlook

7. North America 3D Protein Structure Analysis Market Outlook

8. Europe 3D Protein Structure Analysis Market Outlook

9. Asia-Pacific 3D Protein Structure Analysis Market Outlook

10. South America 3D Protein Structure Analysis Market Outlook

11. Middle East and Africa 3D Protein Structure Analysis Market Outlook

12. Market Dynamics

13. Market Trends & Developments

14. Competitive Landscape (Inclusive SWOT Analysis)

15. Strategic Recommendations

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â